About the job
COMPANY DESCRIPTION
Abiologics, Inc. is an innovative, privately held biotechnology company dedicated to transforming biology through advanced therapeutic modalities. We are leading the charge in developing Synteins™, a groundbreaking class of macromolecular medicines propelled by cutting-edge synthetic and computational technologies. We are on the lookout for outstanding scientists who are fervent about pioneering therapeutic modality innovations within the biotechnology landscape.
Founded within Flagship Pioneering’s venture creation engine, Abiologics has its roots alongside remarkable companies such as Moderna Therapeutics (NASDAQ: MRNA) and Generate Biomedicines. Since its inception in 2000, Flagship has nurtured over 100 scientific ventures, producing more than 500 patents and facilitating over 50 clinical trials for novel therapeutic agents.
THE ROLE
We invite applications for an experienced and driven Senior Scientist in Medicinal Chemistry, with a specialization in miniprotein and peptide drugs. The ideal candidate will be instrumental in the design, synthesis, and optimization of innovative miniprotein therapeutics known as Synteins™. This role provides a distinctive opportunity to guide a new drug modality from early-stage research all the way through clinical development.
KEY RESPONSIBILITIES
- Independently plan, execute, interpret, and enhance Syntein structure-activity campaigns through hands-on laboratory engagement.
- Utilize modern peptide chemistry and conjugation techniques to expedite the optimization of miniprotein drug development.
- Collaborate with interdisciplinary teams, including computational chemistry, biology, and pharmacology, to ensure project success.
- Champion innovation at the bench-side, ensuring a seamless transition from concept to execution.
- Mentor and lead junior scientists, promoting a collaborative and dynamic laboratory environment.
- Contribute to patent applications and scientific publications, highlighting laboratory advancements.

